PRRT2 and nonpapillary renal cell carcinoma: We previously reported that the pVHL‐atypical PKC‐JunB pathway contributed to promote the cell invasiveness and to enhance angiogenesis in ccRCC in a HIF‐independent manner, and we also showed that CCL2 was one of the downstream effectors of JunB by microarray analysis 6.